BGHL (GBP): NAV(s)
()
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.
>> mehr lesen
BGHL (EUR): NAV(s)
()
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.
>> mehr lesen
Transaction in Own Shares
()
ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 2 October 2023 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares
of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 29 September 2023 Aggregate number of
>> mehr lesen
Planisware launches its Initial Public Offering on Euronext Paris and announces indicative price range
()
Regulatory News: Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today the launch of its IPO in view of the admission of its shares to trading on
the regulated market of Euronext Paris (Compartment A). On September 29, 2023, the French Autorité des Marchés Financiers (the “AMF”) granted its approval under the number 23-414 on the prospectus
>> mehr lesen
GeNeuro Reports 2023 Half-Year Results and Provides Corporate Update
()
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases
such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Post-Acute Sequelae of COVID-19 (PASC, long-COVID or post-COVID), today reported its half-year financial results for the
period
>> mehr lesen
Maurel & Prom: Update on activities in Gabon
()
Regulatory News: The Maurel & Prom Group (“M&P”) (Paris:MAU) confirms discussions were held last week between the management of M&P Gabon and the representatives of local communities
around the Ezanga permits following their demands in terms of employment and economic benefits. These discussions took place with the support of the Gabonese authorities and quickly resulted in an
agreement
>> mehr lesen
Cohu Acquires Equiptest Engineering
()
Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced that it has acquired Equiptest Engineering Pte.
Ltd. (“EQT”), a provider of semiconductor test contactors and other consumables with trailing twelve months revenue of approximately $20 million. EQT becomes part of Cohu’s Interface Solutions
>> mehr lesen
DAX-Ausblick: Geht die Erholung weiter?
()
Der DAX (WKN: 846900) hat zum Ende eines enttäuschenden Börsenmonats noch einmal für positive Schlagzeilen gesorgt. Am Donnerstag durchbrach das größte deutsche Börsenbarometer den Negativtrend von
fünf Minustagen in Folge und drehte beim Aufwärtstrend von September 2022 wieder nach oben. Am Freitag ging die Erholung weiter, was den DAX zeitweise zurück über die Marke von 15.500 Punkten führte.
Weiterlesen
>> mehr lesen
Basilea announces FDA acceptance of New Drug Application for antibiotic ceftobiprole
()
Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) Prescription Drug User Fee
Act (PDUFA) goal date set for April 03, 2024 Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, October 02, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN),
>> mehr lesen
Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)
()
Ad hoc announcement pursuant to Art. 53 LR Phase III APPLAUSE-IgAN study met its pre-specified interim analysis primary endpoint, demonstrating superiority of iptacopan vs placebo in proteinuria
reduction1 Iptacopan is an investigational, first-in-class, oral factor B inhibitor targeting the alternative pathway of the complement system2–4 IgAN is a complement-mediated
>> mehr lesen
Basilea gibt bekannt, dass die FDA den Zulassungsantrag für das Antibiotikum Ceftobiprol zur Prüfung angenommen hat
()
Antrag auf Marktzulassung für die Behandlung von Staphylococcus-aureus-Bakteriämie (SAB), akuten bakteriellen Haut- und Weichteilinfektionen (ABSSSI) und ambulant erworbenen bakteriellen
Lungenentzündungen (CABP) 03. April 2024 als PDUFA-Zieldatum für den Abschluss des Prüfungsverfahrens festgelegt Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 02. Oktober 2023 Basilea
>> mehr lesen
EQS-News: Bybit: UAE's Brightest Minds to Enter Bybit's Crypto Hackathon in UAE
()
EQS-News: Bybit / Key word(s): Miscellaneous Bybit: UAE's Brightest Minds to Enter Bybit's Crypto Hackathon in UAE 02.10.2023 / 07:10 CET/CEST The issuer is solely responsible for the content of this
announcement. UAE's Brightest Minds to Enter Bybit's Crypto Hackathon in UAE
>> mehr lesen
Synlab-Aktie +25%: Coronatest-Hersteller vor Übernahme
()
Was sich bereits im März andeutete, ist jetzt eingetreten. Der Hauptaktionär Cinven unterbreitete ein Übernahmeangebot über 10 € pro Synlab-Aktie (WKN: A2TSL7). Daraufhin sprang die Aktie am Freitag
um 24,3% auf 10,10 €. Wie ist die Übernahme zu werten, und welche Folgen hat das für Anleger und Aktionäre? Weiterlesen auf sharedeals.de
>> mehr lesen
Coherent to Demonstrate Next-Generation Transceiver and Semiconductor Laser Technology for 800G and 1.6T Transmission in AI Networks at ECOC 2023
()
The live demonstrations will include the following: OSFP 800G-FR4 DSP-based optical transceiver, highlighting 200G optical lanes OSFP 800G-DR8 linear pluggable optical (LPO) transceiver 200G PAM4
Mach-Zehnder modulated laser with differential driver from Semtech, highlighting advanced integrated InP laser technology PITTSBURGH, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Coherent
>> mehr lesen
Profitability continues to improve; €2.1b revenue, 12.8% EBITDA margin and €112m of profit for the period; ROIC of 10.2% back in value creation territory
()
ARYZTA AG / Key word(s): Interim Report Profitability continues to improve; €2.1b revenue, 12.8% EBITDA margin and €112m of profit for the period; ROIC of 10.2% back in value creation territory
02-Oct-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.
>> mehr lesen
VT5 announces potential business combination with R&S Group
()
VT5 Acquisition Company AG / Key word(s): Mergers & Acquisitions VT5 announces potential business combination with R&S Group 02-Oct-2023 / 07:00 CET/CEST Release of an ad hoc announcement
pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. This announcement or the information
>> mehr lesen
DKSH Healthcare Strengthens its Australian Business with the Acquisition of Partizan
()
DKSH Management Ltd. / Key word(s): Takeover DKSH Healthcare Strengthens its Australian Business with the Acquisition of Partizan 02.10.2023 / 07:00 CET/CEST Media release DKSH has closed the
acquisition of Partizan Worldwide Pty Limited (“Partizan”), a leading
>> mehr lesen
Cosmo und Hikma unterzeichnen Lizenzvertrag für Winlevi in 17 Ländern des Nahen Ostens und Nordafrika
()
Cosmo Pharmaceuticals N.V. / Schlagwort(e): Vereinbarung Cosmo und Hikma unterzeichnen Lizenzvertrag für Winlevi in 17 Ländern des Nahen Ostens und Nordafrika 02.10.2023 / 06:00 GMT/BST Dublin,
Irland – 2. Oktober 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) («Cosmo») und Hikma Pharmaceuticals PLC
>> mehr lesen
Cosmo and Hikma Sign License Agreement for Winlevi in 17 Middle Eastern and North African Countries
()
Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Cosmo and Hikma Sign License Agreement for Winlevi in 17 Middle Eastern and North African Countries 02.10.2023 / 06:00 GMT/BST Dublin, Ireland – 02
October 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hikma Pharmaceuticals PLC (LSE:
>> mehr lesen
PolyPeptide sichert revolvierende Kreditfazilität
()
PolyPeptide Group / Schlagwort(e): Finanzierung PolyPeptide sichert revolvierende Kreditfazilität 02.10.2023 / 07:00 CET/CEST Medienmitteilung PolyPeptide sichert revolvierende Kreditfazilität
Baar, 2. Oktober 2023 – PolyPeptide Group AG (SIX: PPGN) gibt die Unterzeichnung
>> mehr lesen
PolyPeptide secures revolving credit facility
()
PolyPeptide Group / Key word(s): Financing PolyPeptide secures revolving credit facility 02.10.2023 / 07:00 CET/CEST Media Release PolyPeptide secures revolving credit facility Baar, 2 October 2023 –
PolyPeptide Group AG (SIX: PPGN) announces the signing of a revolving
>> mehr lesen
EQS-News: Newron appoints Margarita Chavez as board advisor
()
EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Personnel Newron appoints Margarita Chavez as board advisor 02.10.2023 / 07:00 CET/CEST The issuer is solely responsible for the content
of this announcement. Newron appoints Margarita Chavez as board advisor Margarita Chavez, former
>> mehr lesen
EQS-News: Newron ernennt Margarita Chavez zur Beraterin des Verwaltungsrates
()
EQS-News: Newron Pharmaceuticals S.p.A. / Schlagwort(e): Personalie Newron ernennt Margarita Chavez zur Beraterin des Verwaltungsrates 02.10.2023 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist
der Emittent / Herausgeber verantwortlich. Newron ernennt Margarita Chavez zur Beraterin des Verwaltungsrates
>> mehr lesen
Hexagon Purus Maritime receives purchase order for hydrogen fuel storage system from Hvide Sande Shipyard in Denmark
()
Hexagon Purus Maritime, a wholly owned subsidiary of Hexagon Purus, has received a purchase order for a hydrogen fuel storage system from Hvide Sande Shipyard, a Danish shipyard building and
servicing a wide range of vessel types. Hexagon Purus Maritime’s hydrogen fuel storage system incorporating type 4 hydrogen cylinders will be used as fuel storage onboard the training ship SKULEBAS.
The
>> mehr lesen
WISeKey, WISeSAT, FOSSA Systems, and BA Lab Join Forces to Revolutionize the Logistics Industry with Innovative Satellite Track & Trace Solution
()
WISeKey, WISeSAT, FOSSA Systems, and BA Lab Join Forces to Revolutionize the Logistics Industry with Innovative Satellite Track & Trace Solution Geneva, Madrid Cadiz, October 2, 2023 –
WISeKey, a leading global cybersecurity company, is proud to announce the signing of a Strategic Parnership Agreement with WISeSAT, FOSSA Systems, and BA Lab the technology division of Bernardino
Abad SL
>> mehr lesen
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD
()
Late-breaking results from Phase III trial of OCREVUS (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in multiple sclerosis (MS) will be presented 10-year
OCREVUS efficacy and safety data show significant benefit in slowing long-term disability progression and consistent long-term safety profile in MS Additional OCREVUS real-world and clinical
>> mehr lesen
VGP NV: Voting Rights and Denominator
()
Regulated Information Antwerp, 2 October 2023– 07.00 a.m. CET In application of Article 15 of the Law of May 2, 2007 on the disclosure of major shareholdings in issuers whose shares are admitted for
trading on a regulated market, VGP publishes, by means of a press release and on its website, the total share capital, the total number of securities with voting rights and the total number of
>> mehr lesen
Willis Lease Finance Corporation Announces Teesworks as Site for Innovative New, Power-to-Liquid (PtL) Sustainable Aviation Fuel (SAF) Project
()
Partners with Tees Valley Combined Authority to Launch First PtL SAF Refinery in Northeastern England COCONUT CREEK, Fla., Oct. 01, 2023 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation
(NASDAQ: WLFC) (“WLFC”), a leading lessor of commercial aircraft engines and global provider of aviation services, together with its subsidiary Willis Sustainable Fuels (UK) Limited, today announces
>> mehr lesen
Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase
()
Ghent, BELGIUM, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Press release – Regulated Information Inside information Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director
to lead the company in its next growth phase Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop and
>> mehr lesen
Coherent to Demonstrate Next-Generation Transceiver Technology for Digital Coherent Optics in Ultracompact Pluggable Form Factors for Disaggregated Systems at ECOC 2023
()
The live demonstrations will include the following: 800G coherent optical engine based on the 140 GBaud IC-TROSA from Coherent and the Orion DSP from Marvell 400ZR and 400G OpenZR+ QSFP-DD DCO
transceiver as part of the OIF multi-vendor interoperability showcase 100G QSFP28 0 dBm DCO transceiver PITTSBURGH, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:
>> mehr lesen